نتایج جستجو برای: angiotensin converting enzyme ace inhibitors

تعداد نتایج: 446198  

بقایی, بهروز, ترتیبیان, بختیار, عطار زاده حسینی, سید رضا ,

  Background : The aim of this research is investigation of angiotensin converting enzyme gene expression and angiotensin II activity in middle-aged men , following to eight weeks moderate exercise.   Methods: This study was a semi-experimental research with a repeated measures design. From 96 volunteer middle-aged men, 20 subject (age range of 45-55 years) participated in this study after sign...

Journal: :Heart 2005
D M Shavelle

Angiotensin converting enzyme (ACE) inhibitors may become an accepted form of treatment for aortic stenosis in the future.

Journal: :the journal of tehran university heart center 0
ahmad sharafi tehran heart center, tehran university of medical sciences, tehran, iran. saeed davoodi tehran heart center, tehran university of medical sciences, tehran, iran. abbasali karimi tehran heart center, tehran university of medical sciences, tehran, iran. hosein ahmadi tehran heart center, tehran university of medical sciences, tehran, iran. kyomars abbasi tehran heart center, tehran university of medical sciences, tehran, iran. mahmood sheikh-fathollahi tehran heart center, tehran university of medical sciences, tehran, iran.

background: there is controversy over the potential benefits/harms of the usage of angiotensin-converting enzyme inhibitors (aceis) or angiotensin receptor blockers (arbs) as regards the postoperative mortality of coronary artery bypass grafting (cabg). this study investigates the correlation between the in-hospital mortality of cabg and the preoperative administration of acei/arb. methods: out...

Journal: :The American journal of cardiology 1998
M A Pfeffer M Domanski Y Rosenberg J Verter N Geller P Albert J Hsia E Braunwald

The Prevention of Events with Angiotensin-Converting Enzyme Inhibition (PEACE) trial is an 8,100 patient, randomized, double-blind, placebo-controlled trial designed to determine the usefulness of angiotensin-converting enzyme (ACE) inhibitors in treating coronary patients with preserved left ventricular ejection fraction. The hypothesis being tested in this trial is that patients with coronary...

سیدزاده, ابوالحسن, عمادممتاز, حسین, ملکی, مجید,

Bartter syndrome presenting in neonatal or early infancy is characterized by salt loosing tubulopathy, hypokalemia, and metabolic alkalosis. Failure to thrive is one of the most common findings in neonatal bartter syndrome. Angiotensin converting enzyme inhibitors are one of the therapeutic options for improving growth in these patients.We describe a case of neonatal bartter syndrome with mild ...

Journal: :molecular biology research communications 2015
mostafa saadat

angiotensin converting enzyme (ace; omim: 106180) has an important role in the conversion of angiotensin i to angiotensin ii and degradation of bradykinin. genetic polymorphism i/d (rs4646994) in the gene encoding ace has been well defined. to get more insight into the genetic structure of iranian populations, the distribution of the ace i/d polymorphism among iranians was compared with each ot...

2010
Isuru Wijesekara Se-Kwon Kim

Hypertension or high blood pressure is one of the major independent risk factors for cardiovascular diseases. Angiotensin-I-converting enzyme (EC 3.4.15.1; ACE) plays an important physiological role in regulation of blood pressure by converting angiotensin I to angiotensin II, a potent vasoconstrictor. Therefore, the inhibition of ACE activity is a major target in the prevention of hypertension...

Journal: :European heart journal 2009
Stefan Klotz Daniel Burkhoff Ingrid M Garrelds Frans Boomsma A H Jan Danser

AIMS Angiotensin-converting enzyme inhibitors (ACE-Is) prevent the rise in myocardial angiotensin II that occurs after left ventricular assist device (LVAD) implantation, but do not fully normalize cardiac function. Here, we determined the effect of LVAD implantation, with or without ACE-Is, on cardiac renin, aldosterone, and norepinephrine, since these hormones, like angiotensin II, are likely...

Journal: :Journal of the American College of Cardiology 2005
L Mascitelli F Pezzetta

To the Editor—In their commentary, Chan et al propose that angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) should be considered first-choice antihypertensive therapies for obese patients, given the favourable effects of these agents on glucose metabolism. We agree with this assertion and suggest that the antiinflammatory action of renin-angiotensin blocka...

Journal: :The Indian journal of chest diseases & allied sciences 2013
Vinod Kaura Neil V Kaura Bobby N Kaura Claire S Kaura

Angiotensin-converting enzyme (ACE) is used as a marker for sarcoid disease activity. We present an observational study of four African-American patients all of whom demonstrated improvement in their sarcoidosis after treatment with ACE inhibitors for hypertension.

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید